We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical and Pathophysiological Description of Ocular Ischemic Syndrome

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00403195
First Posted: November 23, 2006
Last Update Posted: September 10, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Rigshospitalet, Denmark
University Hospital, Gentofte, Copenhagen
Information provided by (Responsible Party):
Peter Kofoed, Glostrup University Hospital, Copenhagen
  Purpose
The purpose of this study is to characterize the disease Ocular Ischemic Syndrome.

Condition
Retinal Degeneration Diabetic Retinopathy

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Pathophysiological Analysis of Ocular Ischemic Syndrome and the Response to Vascular Surgery

Resource links provided by NLM:


Further study details as provided by Peter Kofoed, Glostrup University Hospital, Copenhagen:

Enrollment: 13
Study Start Date: November 2006
Study Completion Date: January 2009
Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)
Detailed Description:
The disease Ocular Ischemic Syndrome (OIS) is not a well described entity. It occurs after a long-standing period of extremely low blood supply to the retina caused by atherosclerosis of the carotid arteries. In this study we will analyze why OIS is developed in some patients and not developed in others. The patients with OIS will be thorough examined and will be compared with 1) a control group of healthy people and 2) with control group of patients with diabetic retinopathy. Furthermore the impact of vascular surgery on OIS will be analyzed.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients with the disease ocular ishemic syndrome. Patients will be screened through vascular surgery departments.
Criteria

Inclusion Criteria:

  • Ocular ischemic syndrome

Exclusion Criteria:

  • Any other active ocular disease
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00403195


Locations
Denmark
Department of Ophthalmology, Glostrup Hospital, University of Copenhagen
Glostrup, Denmark, 2600
Sponsors and Collaborators
Glostrup University Hospital, Copenhagen
Rigshospitalet, Denmark
University Hospital, Gentofte, Copenhagen
Investigators
Study Director: Michael Larsen, Professor
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Peter Kofoed, Principal investigator, Glostrup University Hospital, Copenhagen
ClinicalTrials.gov Identifier: NCT00403195     History of Changes
Other Study ID Numbers: OIS
First Submitted: November 21, 2006
First Posted: November 23, 2006
Last Update Posted: September 10, 2012
Last Verified: September 2012

Keywords provided by Peter Kofoed, Glostrup University Hospital, Copenhagen:
Ocular Ischemic Syndrome

Additional relevant MeSH terms:
Diabetic Retinopathy
Retinal Degeneration
Retinal Diseases
Eye Diseases
Diabetic Angiopathies
Vascular Diseases
Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases